Compare JUBILANT LIFE SCIENCES with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES STERLING BIOTECH JUBILANT LIFE SCIENCES/
STERLING BIOTECH
 
P/E (TTM) x 15.4 -0.4 - View Chart
P/BV x 1.8 0.0 12,582.5% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   STERLING BIOTECH
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
STERLING BIOTECH
Dec-13
JUBILANT LIFE SCIENCES/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs89811 8,552.4%   
Low Rs6183 18,161.8%   
Sales per share (Unadj.) Rs572.026.8 2,133.8%  
Earnings per share (Unadj.) Rs36.2-15.0 -242.2%  
Cash flow per share (Unadj.) Rs59.5-5.5 -1,089.4%  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs301.954.9 550.1%  
Shares outstanding (eoy) m159.28267.87 59.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.3 511.0%   
Avg P/E ratio x20.9-0.5 -4,501.5%  
P/CF ratio (eoy) x12.7-1.3 -1,000.8%  
Price / Book Value ratio x2.50.1 1,981.9%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m120,6941,862 6,483.0%   
No. of employees `0002.41.4 176.5%   
Total wages/salary Rs m19,260547 3,522.2%   
Avg. sales/employee Rs Th38,120.65,303.3 718.8%   
Avg. wages/employee Rs Th8,058.4403.8 1,995.4%   
Avg. net profit/employee Rs Th2,414.3-2,959.0 -81.6%   
INCOME DATA
Net Sales Rs m91,1087,181 1,268.8%  
Other income Rs m35743 839.0%   
Total revenues Rs m91,4667,223 1,266.3%   
Gross profit Rs m17,390947 1,836.5%  
Depreciation Rs m3,7092,543 145.8%   
Interest Rs m2,1984,377 50.2%   
Profit before tax Rs m11,840-5,931 -199.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,8020-   
Tax Rs m3,268-1,924 -169.8%   
Profit after tax Rs m5,770-4,007 -144.0%  
Gross profit margin %19.113.2 144.7%  
Effective tax rate %27.632.4 85.1%   
Net profit margin %6.3-55.8 -11.4%  
BALANCE SHEET DATA
Current assets Rs m45,84814,335 319.8%   
Current liabilities Rs m20,89749,809 42.0%   
Net working cap to sales %27.4-494.0 -5.5%  
Current ratio x2.20.3 762.3%  
Inventory Days Days57403 14.1%  
Debtors Days Days51171 29.9%  
Net fixed assets Rs m65,49855,432 118.2%   
Share capital Rs m159268 59.5%   
"Free" reserves Rs m47,93013,935 343.9%   
Net worth Rs m48,08914,701 327.1%   
Long term debt Rs m42,4299,478 447.7%   
Total assets Rs m114,68573,988 155.0%  
Interest coverage x6.4-0.4 -1,799.3%   
Debt to equity ratio x0.90.6 136.9%  
Sales to assets ratio x0.80.1 818.6%   
Return on assets %6.90.5 1,387.1%  
Return on equity %12.0-27.3 -44.0%  
Return on capital %12.4-6.4 -193.2%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m12,4221,860 667.9%   
Fx outflow Rs m17,22725 69,212.5%   
Net fx Rs m-4,8051,835 -261.9%   
CASH FLOW
From Operations Rs m11,2151,719 652.5%  
From Investments Rs m-10,118-3,148 321.4%  
From Financial Activity Rs m6,5741,426 461.0%  
Net Cashflow Rs m7,612-3 -223,888.2%  

Share Holding

Indian Promoters % 45.6 33.9 134.5%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 0.0 -  
FIIs % 21.2 9.9 214.1%  
ADR/GDR % 0.0 16.9 -  
Free float % 21.1 39.3 53.7%  
Shareholders   23,815 21,482 110.9%  
Pledged promoter(s) holding % 15.9 55.9 28.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   PLETHICO PHARMA  BIOCON   J.B.CHEMICALS  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Oct 22, 2019 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - DR. DATSONS LABS COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS